Product Information
INSULIN LISPRO JR 100 UNIT/ML KWIKPEN is a generic product labeled by Eli Lilly and Company, priced at $10.2057 per ML under NDC 00002775205. Its NADAC has been published 292 times since Jan 20, 2021.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002775205
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
INSULIN LISPROApproval Type
Biologic (BLA)
FDA Application
BLA020563On Market Since
2/12/2020
Pharmacological Classes
Price Statistics
The NADAC for INSULIN LISPRO JR 100 UNIT/ML KWIKPEN has been published 292 times since Jan 20, 2021, and over the history we have for it it has declined 40.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.2057 per ML |
|---|---|
| All-time high | $17.1088 (Oct 13, 2021) |
| All-time low | $10.1187 (Jan 18, 2023) |
| 52-week high | $10.2081 |
| 52-week low | $10.1787 |
| Median price | $10.2025 |
| Average price | $11.3935 |
| Largest weekly change | -40.0% (Jan 12, 2022) |
| Weeks tracked | 292 |
| Tracking since | Jan 20, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INSULIN LISPRO JR 100 UNIT/ML KWIKPEN?
The current National Average Drug Acquisition Cost (NADAC) for INSULIN LISPRO JR 100 UNIT/ML KWIKPEN, manufactured by Eli Lilly and Company, is $10.2057 per ML (NDC 00002775205), effective Aug 19, 2026.
How has the price of INSULIN LISPRO JR 100 UNIT/ML KWIKPEN changed over time?
Over the history we have for it, the NADAC for INSULIN LISPRO JR 100 UNIT/ML KWIKPEN has declined 40.3%. It has been tracked across 292 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for INSULIN LISPRO JR 100 UNIT/ML KWIKPEN?
Since Jan 20, 2021, the NADAC for INSULIN LISPRO JR 100 UNIT/ML KWIKPEN has ranged from a low of $10.1187 (Jan 18, 2023) to a high of $17.1088 (Oct 13, 2021), with a median of $10.2025 per ML.
Are there cheaper alternatives to INSULIN LISPRO JR 100 UNIT/ML KWIKPEN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INSULIN LISPRO 100 UNIT/ML VL, is $2.4028 per ML — about 76% below INSULIN LISPRO JR 100 UNIT/ML KWIKPEN.
Who manufactures INSULIN LISPRO JR 100 UNIT/ML KWIKPEN?
INSULIN LISPRO JR 100 UNIT/ML KWIKPEN (NDC 00002775205) is labeled by Eli Lilly and Company, and CMS classifies it as a generic product.